Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea

Table 2 Clinical Parameters Before and After Treatment

	Baseline			Treatment			Before vs. After Treatment Pairwise Comparison (p value)
	Active	Sham	p	Active	Sham	p	Active	Sham
Average SBP, mmHg	121.0 ± 11.6 (10/10)	127 ± 10.3 (10/10)	0.26	126.0 ± 15.8 (10/10)	130.4 ± 14.2 (10/10)	0.54	0.55	0.33
Average DBP, mmHg	75.2 ± 11.1 (10/10)	78.9 ± 11.4 (10/10)	0.11	83.9 ± 10.6 (10/10)	78.7 ± 11.2 (10/10)	0.97	0.34	0.06
Fasting glucose	99.5 ± 17.1 (10/10)	91.1 ± 13.9 (9/10)	0.27	101.6 ± 18.7 (10/10)	91.6 ± 19.3 (9/10)	0.28	0.96	0.92
2 hour Fasting Glucose	142.3 ± 64.3 (10/10)	109.1 ± 58.6 (9/10)	0.26	140.5 ± 38.4 (10/10)	120.0 ± 55.6 (9/10)	0.39	0.89	0.58
LDL, mg/dl	105.3 ± 16.7 (9/10)	109.4 ± 30.4 (8/10)	0.75	114.6 ± 34.3 (9/10)	107.1 ± 40.0 (8/10)	0.89	0.45	0.75
HDL	47.1 ± 18.5 (10/10)	42.2 ± 15.0 (10/10)	0.56	42.0 ± 15.9 (10/10)	40.1 ± 9.0 (10/10)	0.78	0.04	0.86
Cholesterol/HDL	4.1 ± 1.3 (10/10)	5.0 ± 2.4 (10/10)	0.31	4.9 ± 1.8 (10/10)	4.6 ± 1.7 (10/10)	0.86	0.12	0.15
Triglycerides	148.0 ± 128.4 (10/10)	172.9 ± 200.4 (10/10)	0.76	145.8 ± 86.0 (10/10)	173.9 ± 206.8 (10/10)	0.71	0.96	0.92

SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low density lipoprotein, HDL: high density lipoprotein

ISSN: 1532-429X